The Canadian pharmaceutical industry's marketing practices are highly regulated. So do pharma chatbots needs to be reviewed by PAAB? The answer is ...
Marketers in every single industry have been hearing about the importance of artificial intelligence (AI), including pharmaceutical marketers. The major difference between the pharmaceutical industry and the others is that pharma is highly regulated in what it can say and do. So, is PAAB review required for chatbots? The answer is, of course, yes!
Whether a communication from a pharmaceutical company comes from an employee or a chatbot, the regulatory requirements must be treated the same;
For chatbots, the initial submission must include a detailed description of the model determining which scripts are used in which contexts (such that the underlying logic and model assumptions can be reviewed). Again, if applicable, A detailed description of how machine learning will take place must also be included.
-Patrick Massad, Deputy Commissioner, PAAB.
For more on how PAAB reviews chatbots, download the PAAB training document Artificial Intelligence (AI) for Canadian: Pharma: Opportunity or risk?
Want to learn even more than what’s in the training document, then join us at the upcoming PAAB workshop: Download the agenda and register now!
November 22, Toronto
Early Bird Special:
Book by September 28, 2018 and save $50
Marketing 4 Health Inc. is pleased to help raise awareness for the PAAB workshop. We hope to see you there!